In 2020 Filgotinib (Jyseleca) did not seek FDA approval over FDA concerns & pending RCTs on safety & spermatogenesis. Now the results (MANTA & MANTA-RAy) are published showing FIL has no effect on semen & sex hormones. But still no filgotinib in USA https://t.co/4IHoOpylXm https://t.co/VPqW5Ktcc4